trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['t-dxd']
#asco23 tumor agnostic approvals (fda) looks like t-dxd will be making the list soon 
Medical Oncologist.                                            
        
On the trail of #SCIENCE to turn cancer into a manageable chronic disease. #bcsm #crcsm